medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2019, Number 03

<< Back Next >>

Ginecol Obstet Mex 2019; 87 (03)

Long-term morbidity and mortality in women with a history of premature placental abruption normoinserta

Liñayo-Chouza J, Álvarez-Silvares E, Domínguez-Vigo P, Alves-Pérez MT, Castro-Vilar L

Language: Spanish
References: 37
Page: 167-176
PDF size: 255.87 Kb.


ABSTRACT

Objective: To analyze if women with a history of premature placental abruption have a long-term increase in morbidity and mortality.
Materials and Methods: Case-control study with retrospective data collection of pregnant women from the Hospital University Complex of Ourense between 1996 and 2008. The criteria for inclusion in the case group were the history of placental abruption. The control group was constituted by the women with previous and subsequent delivery to the case group and who had not presented placental abruption. The clinical histories were analyzed with data collection of the index pregnancy and a long-term follow-up was carried out to detect the subsequent diagnosis of arterial hypertension, diabetes mellitus, cardiovascular disease, as well as neoplastic and psychiatric pathology. The statistical study was carried out using the SPSS15.0 computer program. Values of p ‹ 0,05 were considered significant results.
Results: A total of 198 women were studied, of which 66 belong to the case group and 132 to the control group. In the follow-up period (15,8 ± 3,58 years) the incidence of diabetes mellitus and dyslipidemia was higher in the case group, but without statistical significance. No differences were found in the incidence of hypertension, metabolic syndrome, cardiovascular disease or anxiety-depressive illness. In the case group, a high rate of oncological pathology was found.
Conclusions: We found no relationship between the history of placental abruption and cardiovascular disease. We lack an explanation that justifies the high rate of tumor pathology in this group of women.


REFERENCES

  1. Ananth CV, et al. Cardiovascular disease in relation to placental abruption: a population-based cohort study from Denmark. Paediatr Perinat Epidemiol 2017;31(3):209-218. http://doi.org/10.1111/ppe.12347

  2. Mosca L, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011;123(11):1243-62. http://doi.org/10.1161/ CIR.0b013e31820faaf8

  3. Neiger R. Long-term effects of pregnancy complications on maternal health: a review. J Clin Med 2017;6(8). http://doi. org/10.3390/jcm6080076.

  4. Williams D. Pregnancy: a stress test for life. Curr Opin Obstet Gynecol 2003;15(6):465-71. http://doi.org/10.1097/01. gco.0000103846.69273.ba

  5. Roberts JM, et al. Pregnancy is a screening test for later life cardiovascular disease: now what? Womens Health Issues 2012;22(2):e123-8. https://doi.org/10.1016/j. whi.2012.01.001

  6. Ray JG, et al. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based restrospective cohort study. Lancet 2005;366(9499):1797-803. http:// doi.org/10.1016/S0140-6736(05)67726-4

  7. Veerbeek JH, et al. Maternal cardiovascular risk profile after placental abruption. Hypertension 2013;61(6):1297- 301. http://doi.org/10. 1161 /HYPERTENSION AHA. 111.00930.

  8. Ananth CV. Ischemic placental disease: a unifying concept for preeclampsia, intrauterine growth restriction and placental abruption. Semin Perinatol 2014;38(3):131-2. http://doi.org/10.1053/j.semperi.2014.03.001

  9. Tikkanen M. Placental abruption: epidemiology, risk factors and consequences. Acta Obstet Gynecol Scand 2011;90(2):140-9. http://doi.org /10.1111/j.1600- 0412.2010.01030.x

  10. Oyelese Y, et al. Placental abruption. Obstet Gynecol 2006;108(4):1005-16. http://doi.org/10.1097/01. AOG.0000239439.04364.9a

  11. Ananth CV, et al. Placental abruption among singleton and twin births in the United States: risk factor profiles. Am J Epidemiol 2001;153(8):771. https://doi.org/10.1093/ aje/153.8.771

  12. World Health Organization. Fact sheet 334: women´s health. Geneva. 2013. Dirección URL: .

  13. Sociedad Española de Ginecología y Obstetricia (SEGO). Protocolo asistencial: Desprendimiento prematuro de placenta normalmente inserta (2013). Dirección URL: .

  14. Chobanian AV, et al. The National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42(6):1206-52. http://doi.org/10.1161/01. HYP.0000107251.49515.c2

  15. ADA 2015: American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2015;38(Suppl.1):S4. https://doi.org/10.2337/dc15-S003

  16. Álvarez-Cosmea A, et al. Dislipemias: manejo de las dislipemias en atención primaria. Barcelona: semFYC Ediciones; 2012. https://www.semfyc.es/wp-content/ uploads/2016/06/Gu%C3%ADa_Dislipemias_2012.pdf

  17. American Psychiatric Association. DSM-5. Manual Diagnóstico y Estadístico de los Trastornos Mentales.DSM-5®. Edición: 5ª. Editorial Médica Panamericana. 2014. 492 pp. https://dsm.psychiatryonline.org/pb-assets/dsm/update/ Spanish_DSM5Update2016.pdf

  18. Edlow AG, et al. Investigating the risk of hypertension shortly after pregnancies complicated by preeclampsia. Am J of Obstet Gynecol 2009;200(5):e60-2. http://doi. org/10.1016/j.ajog.2008.10.012

  19. Adams EM, et al. Long-term effect of preeclampsia on blood pressure. Lancet 1961;2(7217):1373-5. https://doi. org/10.1016/S0140-6736(61)91196-5

  20. Wilson BJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BJM 2003;326(7394):845-51. https://doi. org/10.1136/bmj.326.7394.845

  21. Magnusen EB, et al. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet Gynecol 2009;114:961-70. http://doi.org/10.1097/ AOG.0b013e3181bb0dfc.

  22. Drost J, et al. Cardiovascular risk factors in women 10 years post early preeclampsia: the preeclampsia Risk evaluation in Females study (PREVFEM). Eur J Prev Cardiol 2012:19(5):1138- 1144. http://doi.org/10.1177/1741826711421079.

  23. Bellamy L, et al. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;10(7627):974-84. https://doi. org/10.1136/bmj.39335.385301.BE

  24. Brosens I, et al. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol 2011;204:193-201. http://doi.org/10.1016/j. ajog.2010.08.009

  25. Vázquez-Rodríguez M, et al. Factores clínicos y bioquímicos de riesgo de hipertensión arterial en mujeres con diagnóstico previo de estados hipertensivos del embarazo. Ginecol Obstet Mex 2017;85(5):273-288. https://ginecologiayobstetricia. org.mx/2017/volumen-85-numero-5-mayo-2017/ factores-clinicos-y-bioquimicos-de-riesgo-de-hipertensionarterial- en-mujeres-con-diagnostico-previo-de-estadoshipertensivos- del-embarazo/

  26. Pérez-Adan M, Vázquez-Rodríguez M, Álvarez-Silvares E, Alvez-Pérez MT, Domínguez-Vigo P. Factores de riesgo de enfermedad cardiovascular en gestantes con estados hipertensivos. Experiencia de 10 años. Ginecol Obstet Mex 2016 sept;84(9):573-585. https://ginecologiayobstetricia. org.mx/secciones/articulos-originales-numero83/factoresde- riesgo-de-enfermedad-cardiovascular-en-gestantescon- estados-hipertensivos-experiencia-de-10-anos/

  27. Friedman AM, et al. Prediction and prevention of ischemic placental disease. Semin Perinatol. 2014;38:177-82. http:// doi.org/10.1053/j.semperi.2014.03.002.

  28. Sattar N, et al. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325(7356):157-60. https://doi. org/10.1136/bmj.325.7356.157

  29. Rich-Edwards JW. Reproductive health as a sentinel of chronic disease in women. Womens Health 2009;5(2):101- 5. http://doi.org/10.2217/17455057.5.2.101.

  30. DeRoo L, et al, S. Placental abruption and long-term maternal cardiovascular disease mortality: A population-based registry study in Norway and Sweden. Eur J Epidemiol 2016;31:501- 511. http://doi.org/10.1007/s10654-015-0067-9.

  31. Pariente G, et al. Placental abruption as a significant risk factor for long-term cardiovascular mortality in a follow-up period of more than a decade. Paediatr Perinat Epidemiol 2014;28:32-38. http://doi.org/10.1111/ppe.12089.

  32. Ananth CV, et al. Incidence of placental abruption in relation to cigarette smoking and hypertensive disorders during pregnancy: a meta-analysis of observational studies. Obstet Gynecol. 1999;93:622-8.

  33. Høgberg V, et al. The effect of smoking and hypertensive disorders on placental abruption in Norway 1999–2002. Acta Obstet Gynecol Scand 2007;86:304-9. https://doi. org/10.1080/00016340601134572

  34. Sibai B, et al. Preeclampsia. Lancet 2005;365:785-799. https://1016/S0140-6736(05)17987-2

  35. Lykke JA, et al, Paidas MJ. Mortality of mothers from cardiovascular and non-cardiovascular causes following pregnancy complications in first delivery. Paediatr Perinat Epidemiol 2010;24(4):323-30. http://doi.org/10.1111/ j.1365-3016.2010.01120.x

  36. Riihimäki O, et al. Mortality and causes of death among women with a history of placental abruption. Acta Obstet Gynecol Scand 2017;96(11):1315-132. http://doi. org/10.1111/aogs.13212.

  37. Innes KE, et al. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004;112(2):306-11. https://doi.org/10.1002/ ijc.20402




2020     |     www.medigraphic.com